Drug Pipeline

Hyper-CVAD Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 2
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07564453 Full-course Immunotherapy Combined With Chemotherapy in Newly Diagnosed B-cell Acute… B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Recruiting
Phase 1/2
NCT06287229 Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel… Relapsed/Refractory Recruiting
Phase 1
NCT06466395 A Phase I Study of Hyper-CVAD In Combination With Venetoclax In Pediatric Patients With… Refractory Acute Leukemia Recruiting
Sponsors Running Hyper-CVAD Trials
M.D. Anderson Cancer Center (2) The First Affiliated Hospital of Soochow University (1)
Disease Areas
Leukemia (3) Acute Lymphoblastic Leukemia (ALL) (2)
Get alerts when Hyper-CVAD trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free